Referências
1.Wortsman X, Moreno C, Soto R, Arellano J, Pezo C, Wortsman J. Ultrasound in-depth characterization and staging of hidradenitis suppurativa. Dermatol Surg. 2013;39(12):1835-42.
2.Anduquia-Garay F, Rodriguez-Gutierrez MM, Poveda-Castillo IT, Valdes-Moreno PL, Agudelo-Rios DA, Benavides-Moreno JS, et al. Hidradenitis suppurativa: Basic considerations for its approach: A narrative review. Ann Med Surg (Lond). 2021;68:102679.
3.Elkin K, Daveluy S, Avanaki KM. Hidradenitis suppurativa: Current understanding, diagnostic and surgical challenges, and developments in ultrasound application. Skin Res Technol. 2020;26(1):11-9.
4.Wortsman X. Imaging of Hidradenitis Suppurativa. Dermatol Clin. 2016;34(1):59-68.
5.Oranges T, Vitali S, Benincasa B, Izzetti R, Lencioni R, Caramella D, et al. Advanced evaluation of hidradenitis suppurativa with ultra-high frequency ultrasound: A promising tool for the diagnosis and monitoring of disease progression. Skin Res Technol. 2020;26(4):513-9.
6.Martorell A, Wortsman X, Alfageme F, Roustan G, Arias-Santiago S, Catalano O, et al. Ultrasound Evaluation as a Complementary Test in Hidradenitis Suppurativa: Proposal of a Standarized Report. Dermatol Surg. 2017;43(8):1065-73.
7.Wortsman X. Strong validation of ultrasound as an imaging biomarker in hidradenitis suppurativa. Br J Dermatol. 2021;184(4):591-2.
8.Grand D, Frew JW, Navrazhina K, Krueger JG. Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity. Br J Dermatol. 2021;184(4):688-96.
9.Wortsman X, Castro A, Figueroa A. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS). J Am Acad Dermatol. 2016;75(4):760-7.

Referências:

1.Modarressi A, Nizet C, Lombardi T. Granulomas and nongranulomatous nodules after filler injection: Different complications require different treatments. J Plast Reconstr Aesthet Surg. 2020;73(11):2010-5.
2.Ianhez M, Souza MB, Miot HA. Frequency of Complications of Aesthetic Facial Fillers in Brazil. Plast Reconstr Surg. 2022;149(3):599e-601e.
3.Snozzi P, van Loghem JAJ. Complication Management following Rejuvenation Procedures with Hyaluronic Acid Fillers-an Algorithm-based Approach. Plast Reconstr Surg Glob Open. 2018;6(12):e2061.
4.Wortsman X, Wortsman J. Sonographic outcomes of cosmetic procedures. AJR Am J Roentgenol. 2011;197(5):W910-8.
5.Urdiales-Galvez F, De Cabo-Frances FM, Bove I. Ultrasound patterns of different dermal filler materials used in aesthetics. J Cosmet Dermatol. 2021;20(5):1541-8.
6.Wortsman X, Wortsman J, Orlandi C, Cardenas G, Sazunic I, Jemec GB. Ultrasound detection and identification of cosmetic fillers in the skin. J Eur Acad Dermatol Venereol. 2012;26(3):292-301.
7.Wortsman X. Identification and Complications of Cosmetic Fillers: Sonography First. J Ultrasound Med. 2015;34(7):1163-72.
8.Schelke LW, Cassuto D, Velthuis P, Wortsman X. Nomenclature proposal for the sonographic description and reporting of soft tissue fillers. J Cosmet Dermatol. 2020;19(2):282-8.
9.Ghareeb FM, Hassan MSA, El Nahas MA, Salem M. Complicated Facial Fillers: Management Algorithm. Plast Reconstr Surg Glob Open. 2022;10(7):e4445.
10.Mlosek RK, Migda B, Skrzypek E, Sloboda K, Migda M. The use of high-frequency ultrasonography for the diagnosis of palpable nodules after the administration of dermal fillers. J Ultrason. 2021;20(83):e248-e53.

Referências
1.Presazzi A, Bortolotto C, Zacchino M, Madonia L, Draghi F. Carpal tunnel: Normal anatomy, anatomical variants and ultrasound technique. J Ultrasound. 2011;14(1):40-6.
2.Meyer P, Lintingre PF, Pesquer L, Poussange N, Silvestre A, Dallaudiere B. The Median Nerve at the Carpal Tunnel ... and Elsewhere. J Belg Soc Radiol. 2018;102(1):17.
3.Henry BM, Zwinczewska H, Roy J, Vikse J, Ramakrishnan PK, Walocha JA, et al. The Prevalence of Anatomical Variations of the Median Nerve in the Carpal Tunnel: A Systematic Review and Meta-Analysis. PLoS One. 2015;10(8):e0136477.

Referências Bibliográficas
1.Benlala I, Laurent F, Dournes G. Structural and functional changes in COPD: What we have learned from imaging. Respirology. 2021;26(8):731-41.
2.Bodduluri S, Reinhardt JM, Hoffman EA, Newell JD, Jr., Bhatt SP. Recent Advances in Computed Tomography Imaging in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2018;15(3):281-9.
3.Edwards RM, Kicska G, Schmidt R, Pipavath SN. Imaging of small airways and emphysema. Clin Chest Med. 2015;36(2):335-47, x.
4.Hellemons ME, Moor CC, von der Thusen J, Rossius M, Odink A, Thorgersen LH, et al. Desquamative interstitial pneumonia: a systematic review of its features and outcomes. Eur Respir Rev. 2020;29(156).
5.Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. Chest. 2013;143(5):1436-43.
6.Kauczor HU, Wielputz MO, Jobst BJ, Weinheimer O, Gompelmann D, Herth FJF, et al. Computed Tomography Imaging for Novel Therapies of Chronic Obstructive Pulmonary Disease. J Thorac Imaging. 2019;34(3):202-13.
7.Lynch DA. Progress in Imaging COPD, 2004 - 2014. Chronic Obstr Pulm Dis. 2014;1(1):73-82.
8.Martini K, Frauenfelder T. Emphysema and lung volume reduction: the role of radiology. J Thorac Dis. 2018;10(Suppl 23):S2719-S31.
9.Martini K, Frauenfelder T. Advances in imaging for lung emphysema. Ann Transl Med. 2020;8(21):1467.
10.Ostridge K, Williams NP, Kim V, Harden S, Bourne S, Clarke SC, et al. Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD. Respir Res. 2018;19(1):31.
11.Pipavath SJ, Lynch DA, Cool C, Brown KK, Newell JD. Radiologic and pathologic features of bronchiolitis. AJR Am J Roentgenol. 2005;185(2):354-63.
12.Sheikh K, Coxson HO, Parraga G. This is what COPD looks like. Respirology. 2016;21(2):224-36.
13.Stern EJ, Frank MS. CT of the lung in patients with pulmonary emphysema: diagnosis, quantification, and correlation with pathologic and physiologic findings. AJR Am J Roentgenol. 1994;162(4):791-8.
14.Takahashi M, Fukuoka J, Nitta N, Takazakura R, Nagatani Y, Murakami Y, et al. Imaging of pulmonary emphysema: a pictorial review. Int J Chron Obstruct Pulmon Dis. 2008;3(2):193-204.
15.Tanabe N, Vasilescu DM, Hague CJ, Ikezoe K, Murphy DT, Kirby M, et al. Pathological Comparisons of Paraseptal and Centrilobular Emphysema in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2020;202(6):803-11.
16.Thiboutot J, Yuan W, Park HC, Lerner AD, Mitzner W, Yarmus LB, et al. Current Advances in COPD Imaging. Acad Radiol. 2019;26(3):335-43.
17.Winningham PJ, Martinez-Jimenez S, Rosado-de-Christenson ML, Betancourt SL, Restrepo CS, Eraso A. Bronchiolitis: A Practical Approach for the General Radiologist-Erratum. Radiographics. 2017;37(5):1607.

Referências Bibliográficas
1.Benlala I, Laurent F, Dournes G. Structural and functional changes in COPD: What we have learned from imaging. Respirology. 2021;26(8):731-41.
2.Bodduluri S, Reinhardt JM, Hoffman EA, Newell JD, Jr., Bhatt SP. Recent Advances in Computed Tomography Imaging in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2018;15(3):281-9.
3.Edwards RM, Kicska G, Schmidt R, Pipavath SN. Imaging of small airways and emphysema. Clin Chest Med. 2015;36(2):335-47, x.
4.Hellemons ME, Moor CC, von der Thusen J, Rossius M, Odink A, Thorgersen LH, et al. Desquamative interstitial pneumonia: a systematic review of its features and outcomes. Eur Respir Rev. 2020;29(156).
5.Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. Chest. 2013;143(5):1436-43.
6.Kauczor HU, Wielputz MO, Jobst BJ, Weinheimer O, Gompelmann D, Herth FJF, et al. Computed Tomography Imaging for Novel Therapies of Chronic Obstructive Pulmonary Disease. J Thorac Imaging. 2019;34(3):202-13.
7.Lynch DA. Progress in Imaging COPD, 2004 - 2014. Chronic Obstr Pulm Dis. 2014;1(1):73-82.
8.Martini K, Frauenfelder T. Emphysema and lung volume reduction: the role of radiology. J Thorac Dis. 2018;10(Suppl 23):S2719-S31.
9.Martini K, Frauenfelder T. Advances in imaging for lung emphysema. Ann Transl Med. 2020;8(21):1467.
10.Ostridge K, Williams NP, Kim V, Harden S, Bourne S, Clarke SC, et al. Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD. Respir Res. 2018;19(1):31.
11.Pipavath SJ, Lynch DA, Cool C, Brown KK, Newell JD. Radiologic and pathologic features of bronchiolitis. AJR Am J Roentgenol. 2005;185(2):354-63.
12.Sheikh K, Coxson HO, Parraga G. This is what COPD looks like. Respirology. 2016;21(2):224-36.
13.Stern EJ, Frank MS. CT of the lung in patients with pulmonary emphysema: diagnosis, quantification, and correlation with pathologic and physiologic findings. AJR Am J Roentgenol. 1994;162(4):791-8.
14.Takahashi M, Fukuoka J, Nitta N, Takazakura R, Nagatani Y, Murakami Y, et al. Imaging of pulmonary emphysema: a pictorial review. Int J Chron Obstruct Pulmon Dis. 2008;3(2):193-204.
15.Tanabe N, Vasilescu DM, Hague CJ, Ikezoe K, Murphy DT, Kirby M, et al. Pathological Comparisons of Paraseptal and Centrilobular Emphysema in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2020;202(6):803-11.
16.Thiboutot J, Yuan W, Park HC, Lerner AD, Mitzner W, Yarmus LB, et al. Current Advances in COPD Imaging. Acad Radiol. 2019;26(3):335-43.
17.Winningham PJ, Martinez-Jimenez S, Rosado-de-Christenson ML, Betancourt SL, Restrepo CS, Eraso A. Bronchiolitis: A Practical Approach for the General Radiologist-Erratum. Radiographics. 2017;37(5):1607.

Referências Bibliográficas
1- Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol. 2006;16 (7): 1468-77.
2- Ahuja A, Ying M. Sonographic evaluation of cervical lymphadenopathy: is power Doppler sonography routinely indicated? Ultrasound Med Biol. 2003; 29 (3): 353-9.
3- Chong V. Cervical lymphadenopathy: what radiologists need to know. cancer imaging. 2004; 4 (2): 116-20.
4- Dudea SM, Lenghel M, Botar-Jid C, Vasilescu D, Duma M. Ultrasonography of superficial lymph nodes: benign vs. malignant. Med Ultrason. 2012; 14 (4): 294-306.
5- Gonçalves FG, Ovalle JP, Grieb DFJ, Torres CI, Chankwosky J, DelCarpio-O’Donovan R. Diffusion in the head and neck: an assessment beyond the anatomy. Radiol Bras. 2011; 44 (5): 308–314.
6- Gupta A, Rahman K, Shahid M, Kumar A, Qaseem SM, Hassan SA, et al. Sonographic assessment of cervical lymphadenopathy: role of high-resolution and color Doppler imaging. Head Neck. 2011; 33 (3): 297-302.
7- Hoang JK, Vanka J, Ludwig BJ, Glastonbury CM. Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach. AJR. 2013; 200 (1): W17-25.
8- Ludwig BJ, Wang J, Nadgir RN, Saito N, Castro-Aragon I, Sakai O. Imaging of cervical lymphadenopathy in children and young adults. AJR. 2012; 199 (5): 1105-13.
9- Mouawad F, Rysman B, Russ G, Benoudiba F, Garcia G, Abgral R, Zerdoud S, et al. Cystic form of cervical lymphadenopathy. Guidelines of the French Society of Otorhinolaryngology - Head and Neck Surgery (SFORL). Part 1: Diagnostic procedures for lymphadenopathy in case of cervical mass with cystic aspect. Eur Ann Otorhinolaryngol Head Neck Dis. 2019; 136 (6): 489-496.
10- Rodriguez-Takeuchi SR, Renjifo ME, Medina FJ. RadioGraphics 2019; 39:2023–2037
11- Testa ML, Chojniak R, Sene LS, Damascena AS. Diffusion-weighted magnetic resonance imaging: biomarker for treatment response in oncology. Radiol Bras. 2013; 46 (3): 178–180.
12- Ying M, Ahuja A, Brook F. Accuracy of sonographic vascular features in differentiating different causes of cervical lymphadenopathy. Ultrasound Med Biol. 2004; 30 (4): 441-7.
13- Ying M, Bhatia KS, Lee YP, Yuen HY, Ahuja AT. Review of ultrasonography of malignant neck nodes: greyscale, Doppler, contrast enhancement and elastography. Cancer Imaging. 2014;13 (4): 658-669.

Referências
1. Acosta-Felquer ML, Ruta S, Rosa J, Marin J, Ferreyra-Garrot L, Galimberti ML, et al. Ultrasound entheseal abnormalities at the distal interphalangeal joints and clinical nail involvement in patients with psoriasis and psoriatic arthritis, supporting the nail-enthesitis theory. Semin Arthritis Rheum. 2017;47(3):338-42.
2. Acquacalda E, Albert C, Montaudie H, Fontas E, Danre A, Roux CH, et al. Ultrasound study of entheses in psoriasis patients with or without musculoskeletal symptoms: A prospective study. Joint Bone Spine. 2015;82(4):267-71.
3. Acquitter M, Misery L, Saraux A, Bressollette L, Jousse-Joulin S. Detection of subclinical ultrasound enthesopathy and nail disease in patients at risk of psoriatic arthritis. Joint Bone Spine. 2017;84(6):703-7.
4. Aydin SZ, Castillo-Gallego C, Ash ZR, Marzo-Ortega H, Emery P, Wakefield RJ, et al. Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. Dermatology. 2012;225(3):231-5.
5. Bagel J, Schwartzman S. Enthesitis and Dactylitis in Psoriatic Disease: A Guide for Dermatologists. Am J Clin Dermatol. 2018;19(6):839-52.
6. Cunha JS, Qureshi AA, Reginato AM. Nail Enthesis Ultrasound in Psoriasis and Psoriatic Arthritis: A Report from the 2016 GRAPPA Annual Meeting. J Rheumatol. 2017;44(5):688-90.
7. Eder L, Aydin SZ. Imaging in Psoriatic Arthritis-Insights About Pathogenesis of the Disease. Curr Rheumatol Rep. 2018;20(12):77.
8. Gutierrez M, Wortsman X, Filippucci E, De Angelis R, Filosa G, Grassi W. High-frequency sonography in the evaluation of psoriasis: nail and skin involvement. J Ultrasound Med. 2009;28(11):1569-74.
9. Gutierrez-Manjarrez J, Gutierrez M, Bertolazzi C, Afaro-Rodriguez A, Pineda C. Ultrasound as a useful tool to integrate the clinical assessment of nail involvement in psoriatic arthritis. Reumatologia. 2018;56(1):42-4.
10. Idolazzi L, Zabotti A, Fassio A, Errichetti E, Benini C, Vantaggiato E, et al. The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions. Clin Rheumatol. 2019;38(3):913-20.
11. Krajewska-Wlodarczyk M, Owczarczyk-Saczonek A, Placek W, Wojtkiewicz M, Wiktorowicz A, Wojtkiewicz J. Distal interphalangeal joint extensor tendon enthesopathy in patients with nail psoriasis. Sci Rep. 2019;9(1):3628.
12. McGonagle D, Tan AL, Benjamin M. The nail as a musculoskeletal appendage--implications for an improved understanding of the link between psoriasis and arthritis. Dermatology. 2009;218(2):97-102.
13. McGonagle D, Tan AL. The enthesis in psoriatic arthritis. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S36-9.
14. Mendonca JA, Aydin SZ, D'Agostino MA. The use of ultrasonography in the diagnosis of nail disease among patients with psoriasis and psoriatic arthritis: a systematic review. Adv Rheumatol. 2019;59(1):41.
15. Mondal S, Dutta S, Lahiri D, Sinha D, Sircar G, Mandal AK, et al. Assessment of nail unit structures by ultrasound in patients with psoriatic arthritis and their correlations with disease activity indices: a case-control study. Rheumatol Int. 2018;38(11):2087-93.
16. Naredo E, Janta I, Baniandres-Rodriguez O, Valor L, Hinojosa M, Bello N, et al. To what extend is nail ultrasound discriminative between psoriasis, psoriatic arthritis and healthy subjects? Rheumatol Int. 2019;39(4):697-705.
17. Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, Emery P, et al. The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological study. Rheumatology (Oxford). 2007;46(2):253-6.
18. Zabotti A, Idolazzi L, Batticciotto A, De Lucia O, Scire CA, Tinazzi I, et al. Enthesitis of the hands in psoriatic arthritis: an ultrasonographic perspective. Med Ultrason. 2017;19(4):438-43.

Complementação ao hands onde ultrassonografia

Edição especial para a Jornada Acadêmica da Faculdade de Ciências Médicas da Uerj

Edição especial para a Jornada Acadêmica da Faculdade de Ciências Médicas da Uerj

Edição especial para a Jornada Acadêmica da Faculdade de Ciências Médicas da Uerj

Edição especial de podcasts para a Jornada Acadêmica da Faculdade de Ciências Médicas da Uerj

Melville AR, Kearsley-Fleet L, Buch MH, Hyrich KL. Understanding Refractory Rheumatoid Arthritis: Implications for a Therapeutic Approach. Drugs. 2020;80(9):849-57.
Buch MH, Eyre S, McGonagle D. Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis. Nat Rev Rheumatol. 2021;17(1):17-33.
Buch MH. Defining refractory rheumatoid arthritis. Ann Rheum Dis. 2018;77(7):966-9.

PODCAST DA AULA MINISTRADA NA JORNADA DE REUMATOLOGIA DO RIO DE JANEIRO 2021

Referências
1.Kanmaniraja D, Le J, Hsu K, Lee JS, McClelland A, Slasky SE, et al. Review of COVID-19, part 2: Musculoskeletal and neuroimaging manifestations including vascular involvement of the aorta and extremities. Clin Imaging. 2021;79:300-13.
2.Crivelenti L, Frazao MMN, Maia MPM, Gomes FHR, de Carvalho LM. Chronic arthritis related to SARS-CoV-2 infection in a pediatric patient: A case report. Braz J Infect Dis. 2021;25(3):101585.
3.Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, et al. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020;102(14):1197-204.
4.Ramani SL, Samet J, Franz CK, Hsieh C, Nguyen CV, Horbinski C, et al. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol. 2021;50(9):1763-73.
5.Revzin MV, Raza S, Srivastava NC, Warshawsky R, D'Agostino C, Malhotra A, et al. Multisystem Imaging Manifestations of COVID-19, Part 2: From Cardiac Complications to Pediatric Manifestations. Radiographics. 2020;40(7):1866-92.
6.Patel Z, Franz CK, Bharat A, Walter JM, Wolfe LF, Koralnik IJ, et al. Diaphragm and Phrenic Nerve Ultrasound in COVID-19 Patients and Beyond: Imaging Technique, Findings, and Clinical Applications. J Ultrasound Med. 2021.
7.Taleja H. Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin. Dubai Med J. 2021.
8.Conway R, Konig MF, Graef ER, Webb K, Yazdany J, Kim AHJ. Inflammatory arthritis in patients with COVID-19. Transl Res. 2021;232:49-59.
9.Kobayashi S, Taniguchi Y, Kida I, Tamura N. SARS-CoV2-triggered acute arthritis: Viral arthritis rather than reactive arthritis. J Med Virol. 2021.
10.Colatutto D, Sonaglia A, Zabotti A, Cereser L, Girometti R, Quartuccio L. Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature. Viruses. 2021;13(8).
11.Hoong CWS, Amin M, Tan TC, Lee JE. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms. Int J Infect Dis. 2021;104:363-9.
12.Kocyigit BF, Akyol A. Reactive arthritis after COVID-19: a case-based review. Rheumatol Int. 2021;41(11):2031-9.
13.Mukarram MS, Ishaq Ghauri M, Sethar S, Afsar N, Riaz A, Ishaq K. COVID-19: An Emerging Culprit of Inflammatory Arthritis. Case Rep Rheumatol. 2021;2021:6610340.
14.Zacharias H, Dubey S, Koduri G, D'Cruz D. Rheumatological complications of Covid 19. Autoimmun Rev. 2021;20(9):102883.
15.Ciaffi J, Mancarella L, Borlandelli E, Facchini G, Meliconi R, Ursini F. May polyenthesitis follow COVID-19? Joint Bone Spine. 2021;88(3):105158.
16.Zeidler H, Hudson AP. Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens. Curr Rheumatol Rep. 2021;23(7):53.
17.Bureau BL, Obeidat A, Dhariwal MS, Jha P. Peripheral Neuropathy as a Complication of SARS-Cov-2. Cureus. 2020;12(11):e11452.
18.Soliman SB, Klochko CL, Dhillon MK, Vandermissen NR, van Holsbeeck MT. Peripheral Polyneuropathy Associated with COVID-19 in Two Patients: A Musculoskeletal Ultrasound Case Report. J Med Ultrasound. 2020;28(4):249-52.
19.Finsterer J. Comment on Peripheral Polyneuropathy Associated with COVID-19 in Two Patients: A Musculoskeletal Ultrasound Case Report. J Med Ultrasound. 2021;29(2):134-5.
20.Soliman SB. Reply to Comment on Peripheral Polyneuropathy Associated with COVID-19 in Two Patients: A Musculoskeletal Ultrasound Case Report. J Med Ultrasound. 2021;29(2):136-7.
21.Cantarelli Rodrigues T, Hidalgo PF, Skaf AY, Serfaty A. Subacromial-subdeltoid bursitis following COVID-19 vaccination: a case of shoulder injury related to vaccine administration (SIRVA). Skeletal Radiol. 2021;50(11):2293-7.

REFERÊNCIAS
1.Pontone G, Scafuri S, Mancini ME, Agalbato C, Guglielmo M, Baggiano A, et al. Role of computed tomography in COVID-19. J Cardiovasc Comput Tomogr. 2021;15(1):27-36.
2.Cereser L, Da Re J, Zuiani C, Girometti R. Chest high-resolution computed tomography is associated to short-time progression to severe disease in patients with COVID-19 pneumonia. Clin Imaging. 2021;70:61-6.
3.Hochhegger B, Mandelli NS, Stuker G, Meirelles GSP, Zanon M, Mohammed TL, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia Presentations in Chest Computed Tomography: A Pictorial Review. Curr Probl Diagn Radiol. 2021;50(3):436-42.
4.Besutti G, Ottone M, Fasano T, Pattacini P, Iotti V, Spaggiari L, et al. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol. 2021.
5.Mogami R, Lopes AJ, Araujo Filho RC, de Almeida FCS, Messeder A, Koifman ACB, et al. Chest computed tomography in COVID-19 pneumonia: a retrospective study of 155 patients at a university hospital in Rio de Janeiro, Brazil. Radiol Bras. 2021;54(1):1-8.
6.Cau R, Falaschi Z, Pasche A, Danna P, Arioli R, Arru CD, et al. CT findings of COVID-19 pneumonia in ICU-patients. J Public Health Res. 2021.
7.Kanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, et al. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021;299(3):E262-E79.
8.Pourhoseingholi MA, Jafari R, Jafari NJ, Rahimi-Bashar F, Nourbakhsh M, Vahedian-Azimi A, et al. Predicting 1-year post-COVID-19 mortality based on chest computed tomography scan. J Med Virol. 2021;93(10):5694-6.
9.Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, et al. Imaging of COVID-19: An update of current evidences. Diagn Interv Imaging. 2021;102(9):493-500.
10.Ozer H, Kilincer A, Uysal E, Yormaz B, Cebeci H, Durmaz MS, et al. Diagnostic performance of Radiological Society of North America structured reporting language for chest computed tomography findings in patients with COVID-19. Jpn J Radiol. 2021;39(9):877-88.
11.Ramanan RV, Joshi AR, Venkataramanan A, Nambi SP, Badhe R. Incidental chest computed tomography findings in asymptomatic Covid-19 patients. A multicentre Indian perspective. Indian J Radiol Imaging. 2021;31(Suppl 1):S45-S52.
12.Axiaq A, Almohtadi A, Massias SA, Ngemoh D, Harky A. The role of computed tomography scan in the diagnosis of COVID-19 pneumonia. Curr Opin Pulm Med. 2021;27(3):163-8.
13.Ishfaq A, Yousaf Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, et al. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open. 2021;8:100350.
14.Razek A, Fouda N, Fahmy D, Tanatawy MS, Sultan A, Bilal M, et al. Computed tomography of the chest in patients with COVID-19: what do radiologists want to know? Pol J Radiol. 2021;86:e122-e35.
15.Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, Lapotre T, Mompoint D, et al. Study of Thoracic CT in COVID-19: The STOIC Project. Radiology. 2021;301(1):E361-E70.
16.Au-Yong I, Higashi Y, Giannotti E, Fogarty A, Morling JR, Grainge M, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2021:210986.
17.Little BP. Disease Severity Scoring for COVID-19: A Welcome (Semi)Quantitative Role for Chest Radiography. Radiology. 2021:212212.
18.Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L, et al. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020;296(2):E97-E104.
19.Ozel M, Aslan A, Arac S. Use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest computed tomography involvement score (CT-IS) in COVID-19 pneumonia. Radiol Med. 2021;126(5):679-87.
20.Byrne D, Neill SBO, Muller...

REFERÊNCIAS
1.Pontone G, Scafuri S, Mancini ME, Agalbato C, Guglielmo M, Baggiano A, et al. Role of computed tomography in COVID-19. J Cardiovasc Comput Tomogr. 2021;15(1):27-36.
2.Cereser L, Da Re J, Zuiani C, Girometti R. Chest high-resolution computed tomography is associated to short-time progression to severe disease in patients with COVID-19 pneumonia. Clin Imaging. 2021;70:61-6.
3.Hochhegger B, Mandelli NS, Stuker G, Meirelles GSP, Zanon M, Mohammed TL, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia Presentations in Chest Computed Tomography: A Pictorial Review. Curr Probl Diagn Radiol. 2021;50(3):436-42.
4.Besutti G, Ottone M, Fasano T, Pattacini P, Iotti V, Spaggiari L, et al. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol. 2021.
5.Mogami R, Lopes AJ, Araujo Filho RC, de Almeida FCS, Messeder A, Koifman ACB, et al. Chest computed tomography in COVID-19 pneumonia: a retrospective study of 155 patients at a university hospital in Rio de Janeiro, Brazil. Radiol Bras. 2021;54(1):1-8.
6.Cau R, Falaschi Z, Pasche A, Danna P, Arioli R, Arru CD, et al. CT findings of COVID-19 pneumonia in ICU-patients. J Public Health Res. 2021.
7.Kanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, et al. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021;299(3):E262-E79.
8.Pourhoseingholi MA, Jafari R, Jafari NJ, Rahimi-Bashar F, Nourbakhsh M, Vahedian-Azimi A, et al. Predicting 1-year post-COVID-19 mortality based on chest computed tomography scan. J Med Virol. 2021;93(10):5694-6.
9.Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, et al. Imaging of COVID-19: An update of current evidences. Diagn Interv Imaging. 2021;102(9):493-500.
10.Ozer H, Kilincer A, Uysal E, Yormaz B, Cebeci H, Durmaz MS, et al. Diagnostic performance of Radiological Society of North America structured reporting language for chest computed tomography findings in patients with COVID-19. Jpn J Radiol. 2021;39(9):877-88.
11.Ramanan RV, Joshi AR, Venkataramanan A, Nambi SP, Badhe R. Incidental chest computed tomography findings in asymptomatic Covid-19 patients. A multicentre Indian perspective. Indian J Radiol Imaging. 2021;31(Suppl 1):S45-S52.
12.Axiaq A, Almohtadi A, Massias SA, Ngemoh D, Harky A. The role of computed tomography scan in the diagnosis of COVID-19 pneumonia. Curr Opin Pulm Med. 2021;27(3):163-8.
13.Ishfaq A, Yousaf Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, et al. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open. 2021;8:100350.
14.Razek A, Fouda N, Fahmy D, Tanatawy MS, Sultan A, Bilal M, et al. Computed tomography of the chest in patients with COVID-19: what do radiologists want to know? Pol J Radiol. 2021;86:e122-e35.
15.Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, Lapotre T, Mompoint D, et al. Study of Thoracic CT in COVID-19: The STOIC Project. Radiology. 2021;301(1):E361-E70.
16.Au-Yong I, Higashi Y, Giannotti E, Fogarty A, Morling JR, Grainge M, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2021:210986.
17.Little BP. Disease Severity Scoring for COVID-19: A Welcome (Semi)Quantitative Role for Chest Radiography. Radiology. 2021:212212.
18.Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L, et al. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020;296(2):E97-E104.
19.Ozel M, Aslan A, Arac S. Use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest computed tomography involvement score (CT-IS) in COVID-19 pneumonia. Radiol Med. 2021;126(5):679-87.
20.Byrne D, Neill SBO, Muller...

REFERÊNCIAS
1.Pontone G, Scafuri S, Mancini ME, Agalbato C, Guglielmo M, Baggiano A, et al. Role of computed tomography in COVID-19. J Cardiovasc Comput Tomogr. 2021;15(1):27-36.
2.Cereser L, Da Re J, Zuiani C, Girometti R. Chest high-resolution computed tomography is associated to short-time progression to severe disease in patients with COVID-19 pneumonia. Clin Imaging. 2021;70:61-6.
3.Hochhegger B, Mandelli NS, Stuker G, Meirelles GSP, Zanon M, Mohammed TL, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia Presentations in Chest Computed Tomography: A Pictorial Review. Curr Probl Diagn Radiol. 2021;50(3):436-42.
4.Besutti G, Ottone M, Fasano T, Pattacini P, Iotti V, Spaggiari L, et al. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol. 2021.
5.Mogami R, Lopes AJ, Araujo Filho RC, de Almeida FCS, Messeder A, Koifman ACB, et al. Chest computed tomography in COVID-19 pneumonia: a retrospective study of 155 patients at a university hospital in Rio de Janeiro, Brazil. Radiol Bras. 2021;54(1):1-8.
6.Cau R, Falaschi Z, Pasche A, Danna P, Arioli R, Arru CD, et al. CT findings of COVID-19 pneumonia in ICU-patients. J Public Health Res. 2021.
7.Kanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, et al. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021;299(3):E262-E79.
8.Pourhoseingholi MA, Jafari R, Jafari NJ, Rahimi-Bashar F, Nourbakhsh M, Vahedian-Azimi A, et al. Predicting 1-year post-COVID-19 mortality based on chest computed tomography scan. J Med Virol. 2021;93(10):5694-6.
9.Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, et al. Imaging of COVID-19: An update of current evidences. Diagn Interv Imaging. 2021;102(9):493-500.
10.Ozer H, Kilincer A, Uysal E, Yormaz B, Cebeci H, Durmaz MS, et al. Diagnostic performance of Radiological Society of North America structured reporting language for chest computed tomography findings in patients with COVID-19. Jpn J Radiol. 2021;39(9):877-88.
11.Ramanan RV, Joshi AR, Venkataramanan A, Nambi SP, Badhe R. Incidental chest computed tomography findings in asymptomatic Covid-19 patients. A multicentre Indian perspective. Indian J Radiol Imaging. 2021;31(Suppl 1):S45-S52.
12.Axiaq A, Almohtadi A, Massias SA, Ngemoh D, Harky A. The role of computed tomography scan in the diagnosis of COVID-19 pneumonia. Curr Opin Pulm Med. 2021;27(3):163-8.
13.Ishfaq A, Yousaf Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, et al. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open. 2021;8:100350.
14.Razek A, Fouda N, Fahmy D, Tanatawy MS, Sultan A, Bilal M, et al. Computed tomography of the chest in patients with COVID-19: what do radiologists want to know? Pol J Radiol. 2021;86:e122-e35.
15.Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, Lapotre T, Mompoint D, et al. Study of Thoracic CT in COVID-19: The STOIC Project. Radiology. 2021;301(1):E361-E70.
16.Au-Yong I, Higashi Y, Giannotti E, Fogarty A, Morling JR, Grainge M, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2021:210986.
17.Little BP. Disease Severity Scoring for COVID-19: A Welcome (Semi)Quantitative Role for Chest Radiography. Radiology. 2021:212212.
18.Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L, et al. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020;296(2):E97-E104.
19.Ozel M, Aslan A, Arac S. Use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest computed tomography involvement score (CT-IS) in COVID-19 pneumonia. Radiol Med. 2021;126(5):679-87.
20.Byrne D, Neill SBO, Muller...